尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Proxy Form for Extraordinary General Meeting
2018-11-12
Proxy Form for the Class Meeting of H Shareholders
2018-11-12
Proxy Form for the Solicitation of Voting Rights by Independent Non-executive Di
2018-11-12
Proxy Form for the Solicitation of Voting Rights by Independent Non-executive Di
2018-11-12
ACQUISITION OF TARGET EQUITY IN XINCAT PHARMACEUTICAL
2018-11-06
Overseas Regulatory Announcement
2018-11-06
PROPOSED ADOPTION OF THE SHARE OPTION SCHEME AND THE GRANT THEREUNDER
2018-11-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2018-11-01
RENEWAL OF SXPGC AGREEMENT AND SHHCC AGREEMENT
2018-10-22
SUBMISSION OF BIDDING APPLICATIONS IN OPEN TENDERS FOR ACQUIRING EQUITY INTEREST
2018-10-22
<
...
24
25
26
27
28
29
30
...
>
